Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TANGO: Temsirolimus for Below-the-Knee Lesions in CLI
NCT02908035Phase 2Unknown
- Sponsor
- Mercator MedSystems
- Start
- Mar 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in critical limb ischemia (CLI), sponsored by Mercator MedSystems. Status: unknown.
02
Drugs
temsirolimus
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02908035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02908035.